HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pocono Organics Sprouts Full-Spectrum Cannabinoids Line Grown In Regenerative Farming

Executive Summary

Pennsylvania firm's CBD line is only one with the Rodale Institute’s logo to indicate the high standards and responsible farming practices used to make the items. The line includes artisanal, small-batch tinctures, creams, salve sticks, lip balms, massage oil and bath bombs.

You may also be interested in...



Absence Of Federal CBD Regulatory Pathway Complicates Doing Business In US, Clips Sales

“Irrational exuberance was an understatement for what people thought of the CBD market in 2018 and 2019,” says an attorney specializing in hemp regulations. In 2019, CBD isolate could be sold for “upwards of $12,000 a kilogram,” but price now is less than $1,000.

Legislating Hemp As Dietary Ingredient: Wrapping US Market In A Bow, Or Tying DSHEA In Knots?

House legislation to exempt hemp-derived cannabinoids from FDA rule that an “article” previously studied or approved for use as drugs is not allowed for use in dietary supplements either resolves a conundrum or raises additional questions for the agency and the industry.

Tests Show CBD Levels In Some Supplements Don't Match Labeling

Seven of 10 CBD-containing supplement products tested in a lab did not contain the levels of CBD advertised on the label, says hemp, CBD and natural health product information publisher Remedy Reviews. Most products also were found to contain heavy metals.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151236

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel